Search for: "COOPER, M.D."
Results 121 - 140
of 281
Sorted by Relevance
|
Sort by Date
30 Dec 2011, 3:20 am
Supp. 2d 1255 (M.D. 2009). [read post]
17 Apr 2011, 7:16 pm
Goodhart, M.D., J.D. [read post]
28 Sep 2007, 9:00 pm
LEXIS 71370 (M.D. [read post]
17 Aug 2011, 4:45 pm
Jaquith has recalled its products and is cooperating fully with the investigation. [read post]
17 Apr 2011, 7:16 pm
Goodhart, M.D., J.D. [read post]
15 Aug 2023, 6:51 am
Work in a collegial and cooperative manner with the faculty supervisor and other co-workers. [read post]
17 Apr 2011, 7:16 pm
Goodhart, M.D., J.D. 6065 Roswell Rd. [read post]
13 Mar 2009, 2:56 am
LEXIS 17707 (M.D. [read post]
15 Aug 2023, 6:52 am
Work in a collegial and cooperative manner with the faculty supervisor and other co-workers. [read post]
14 Jan 2014, 2:04 pm
Supp. 505, 510 (M.D. [read post]
16 Sep 2022, 5:00 am
McGinnis, No. 1:19-CV-00927 (M.D. [read post]
28 Feb 2022, 3:00 am
., No. 3:20-CV-00751-MEM (M.D. [read post]
3 Jul 2017, 2:44 pm
Brian Xu, M.D., Ph.D., DABT® On June 1, 2017, in the People’s Republic of China (China), the newly revised Regulation on Pesticide Administration (RPA) became effective. [read post]
19 Jun 2017, 6:43 am
Brian Xu, M.D., Ph.D., DABT® On June 1, 2017, in the People’s Republic of China (China), a newly revised Regulation on Pesticide Administration (RPA) became effective. [read post]
2 Apr 2012, 10:00 am
Insel, M.D. [read post]
6 May 2009, 3:01 pm
Maisel, M.D., M.P.H., Director, Medical Device Safety Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Boston Gregory Curfman, M.D., Editor, New England Journal of Medicine Bridget Robb, Gwynedd, Pennsylvania Richard Cooper, Partner, Williams & Connolly LLP Michael Kinsley, Seattle, Washington Transcripts of their testimony and audio from the hearing is available, now [read post]
24 Aug 2009, 3:30 pm
Fauci, M.D. [read post]
24 Mar 2010, 4:32 am
M.D. [read post]
5 Apr 2012, 11:54 am
Supp.2d ___, 2012 WL 1058870, at *5 (M.D. [read post]
31 Oct 2012, 2:26 pm
“Because the preliminary results of the FDA’s inspection raise concerns about the sterility assurance of Ameridose’s products, the FDA is advising health care professionals to stop using all Ameridose products and follow the recall procedures provided by the firm,” explained Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research.The FDA has identified some Ameridose products that currently appear on the critical shortage list. [read post]
